| scholarly article | Q13442814 |
| P50 | author | Maciej Lalowski | Q54447380 |
| Filippo Maria Santorelli | Q60541206 | ||
| Francesco Pezzini | Q91644970 | ||
| P2093 | author name string | Katja M Kanninen | |
| Rabah Soliymani | |||
| Giovanni Signore | |||
| Silvia Rocchiccioli | |||
| Claudia Nesti | |||
| Alessandro Simonati | |||
| Federica Morani | |||
| Stefano Doccini | |||
| Mikko T Huuskonen | |||
| Giulio Calza | |||
| Marc H Baumann | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Fission and selective fusion govern mitochondrial segregation and elimination by autophagy | Q24652230 | ||
| Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis | Q24791822 | ||
| Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins | Q28115540 | ||
| The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain | Q28584778 | ||
| A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging | Q28593206 | ||
| Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells | Q28730871 | ||
| Analysis and interpretation of microplate-based oxygen consumption and pH data | Q30871014 | ||
| Alterations in ROS Activity and Lysosomal pH Account for Distinct Patterns of Macroautophagy in LINCL and JNCL Fibroblasts | Q31110961 | ||
| Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy. | Q33686331 | ||
| Neuroblastoma cell lines--a versatile in vitro model in neurobiology | Q34236052 | ||
| Human pathology in NCL | Q34314766 | ||
| An atypical case of neuronal ceroid lipofuscinosis with co-inheritance of a variably penetrant POLG1mutation | Q34315263 | ||
| Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach. | Q34331197 | ||
| Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease). | Q34535168 | ||
| Easy quantitative assessment of genome editing by sequence trace decomposition | Q34712139 | ||
| Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease | Q35200884 | ||
| Improved vectors and genome-wide libraries for CRISPR screening | Q35215629 | ||
| Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | Q35877183 | ||
| Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules. | Q35879035 | ||
| Genetics of the neuronal ceroid lipofuscinoses (Batten disease). | Q36053005 | ||
| Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice | Q36683039 | ||
| Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL. | Q37248270 | ||
| Mitochondrial division occurs concurrently with autophagosome formation but independently of Drp1 during mitophagy | Q37488331 | ||
| Causal analysis approaches in Ingenuity Pathway Analysis | Q37592031 | ||
| Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway | Q37649077 | ||
| Lysosome-dependent pathways as a unifying theme in Parkinson's disease. | Q38038561 | ||
| Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum | Q38115191 | ||
| Human NCL Neuropathology | Q38386240 | ||
| Cell biology of the NCL proteins: What they do and don't do. | Q38473278 | ||
| Phenotype and natural history of variant late infantile ceroid-lipofuscinosis 5. | Q38764734 | ||
| Oxidative damage and redox in Lysosomal Storage Disorders: Biochemical markers | Q38771207 | ||
| Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells. | Q38888358 | ||
| Neuronal ceroid lipofuscinosis: a common pathway? | Q40181051 | ||
| Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis | Q40794276 | ||
| Additive effect of nuclear and mitochondrial mutations in a patient with mitochondrial encephalomyopathy | Q41306870 | ||
| The Networks of Genes Encoding Palmitoylated Proteins in Axonal and Synaptic Compartments Are Affected in PPT1 Overexpressing Neuronal-Like Cells | Q41525295 | ||
| Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder. | Q41664817 | ||
| BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke | Q42465792 | ||
| Anomalies of mitochondrial ATP synthase regulation in four different types of neuronal ceroid lipofuscinosis | Q42470197 | ||
| Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay | Q42484599 | ||
| Involvement of the mitochondrial compartment in human NCL fibroblasts | Q42497684 | ||
| Estrogenic regulation of skeletal muscle proteome: a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy. | Q47103956 | ||
| Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. | Q47321665 | ||
| Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism | Q48767197 | ||
| Characterizing the Key Metabolic Pathways of the Neonatal Mouse Heart Using a Quantitative Combinatorial Omics Approach | Q52562672 | ||
| Study of Intraventricular Cerliponase Alfa for CLN2 Disease. | Q54229270 | ||
| Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. | Q54584980 | ||
| The Implications of Autophagy in Alzheimer's disease | Q57026082 | ||
| Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity | Q57492135 | ||
| Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease | Q60907590 | ||
| Autophagy and Mitochondria: Targets in Neurodegenerative Disorders | Q64863217 | ||
| ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy | Q84788113 | ||
| Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease | Q85816986 | ||
| Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis | Q87424025 | ||
| Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome | Q90001059 | ||
| Mitochondrial dynamics: overview of molecular mechanisms | Q90374857 | ||
| PARL deficiency in mouse causes Complex III defects, coenzyme Q depletion, and Leigh-like syndrome | Q90711435 | ||
| Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study | Q91386502 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 18 | |
| P577 | publication date | 2020-03-30 | |
| P1433 | published in | Cell Death Discovery | Q27726740 |
| P1476 | title | Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction | |
| P478 | volume | 6 |
Search more.